Diabetic retinopathy is the most common cause of permanent vision loss among working-age individuals in the United States. Currently, there are excellent treatment options available either commercially or in research trials.
In the video below, Dr. Omar Punjabi discusses the newest treatments and clinical trials taking place for diabetic retinopathy.
If you don’t like the video or want more information, continue reading.
Diabetic retinopathy treatments
The Diabetic Retinopathy Clinical Research Network is a network of retina specialists that are actively studying this disease in research trials, and are working towards finding the newest and best treatments for blinding complications of diabetes in the eye.
Several newer imaging methods can non-invasively and quickly detect retinal problems early in diabetic eyes.
Office-based laser procedures are commercially available now and have been shown to reduce retinal swelling, and block the progression of blood vessels that cause complications in diabetics.
There are exciting new injectable medications that block Vascular Endothelial Growth Factor (VEGF), a molecule that leads to complications in the retina.
Currently, the commercially available anti-VEGF treatment agents include:
These medications have excellent success rates for the treatment of diabetic retinopathy and have saved vision in a lot of patients.
Other experimental molecules are currently being tested in clinical trials. There are newer steroid based implants that can last a long time in the eye and maintain vision in diabetics. In fact, one of these implants can last up to 3 years in the eye!
If you want to learn more about these exciting new treatments, make sure you schedule an appointment with your local eye care professional today!